Medicus Sciences Acquisition Corp. (the “Company”) (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Charter”), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.18.
Titanium Miner LB Group Seeks to Shine in Hong Kong IPO Raising up to $1.5 Billion
Key Takeaways:
LB Group has filed for a Hong Kong IPO to raise up to $1.5 billion, aiming to consolidate its place as Asia’s leading producer of titanium dioxide pigments
Listing would complement company’s existing Shenzhen A-shares, which look sharply undervalued compared with industry peers
By Andrew Curran
